Christine A. Pratilas

Also affiliated with Sidney Kimmel Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.257Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Update for NCI-COG Pediatric MATCH: Active trial cohorts for children, adolescents and young adults with refractory cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps10071

Top 59%

0.257DataRank

Top 59%3 citations

Katherine A. Janeway, Theodore W. Laetsch, Meredith S. Irwin, Elizabeth Alva, Christine A. Pratilas +14 more

Papers

Driven by 27 papers — median percentile 41. Top paper: “Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1”.

Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1

Genes(2020)10.3390/genes11020226

N/A

0.751DataRank · unranked

21 citations

Robert J. Allaway, Jaclyn N. Taroni, Aaron Baker, Xiaochun Zhang, Chang In Moon +7 more

Update for NCI-COG Pediatric MATCH: Active trial cohorts for children, adolescents and young adults with refractory cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps10071

Top 59%

0.257DataRank

Top 59%3 citations

Katherine A. Janeway, Theodore W. Laetsch, Meredith S. Irwin, Elizabeth Alva, Christine A. Pratilas +14 more

Integrative analysis identifies candidate tumor microenvironment and intracellular signaling pathways that define tumor heterogeneity in NF1

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.13.904771

N/A

0.208DataRank · unranked

3 citations

Robert J. Allaway, Jaclyn N. Taroni, Aaron Baker, Xiaochun Zhang, Chang In Moon +7 more

Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAFV600E-Mutant Human Glioma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2660

N/A

0DataRank · unranked

40 citations

Andrew Morin, Guisheng Zhao, Amy N. Allen, Patrick Flannery, Michael Glantz +13 more

Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling

Disease Models & Mechanisms(2021)10.1242/dmm.047621

N/A

0DataRank · unranked

33 citations

Igor Odintsov, Zebing Liu, Allan J.W. Lui, Takuo Hayashi, Morana Vojnic +22 more

Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma

medRxiv(2021)10.1101/2021.09.09.21262860

N/A

0DataRank · unranked

1 citations

Christopher Douville, Natalie Silliman, Janine Ptak, Lisa Dobbyn, Joy Schaefer +10 more

Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma

Oncogene(2022)10.1038/s41388-022-02305-x

N/A

0DataRank · unranked

41 citations

Marielle E. Yohe, Kai Pollard, Angelina V. Vaseva, Ana Calizo, Lindy Zhang +10 more

Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy

Science Advances(2022)10.1126/sciadv.abo5442

N/A

0DataRank · unranked

34 citations

Feng Zhang, Rohit Rao, Mike Adam, Kai Pollard, Sara Szabo +16 more

Therapeutic Vulnerability to ATR Inhibition in Concurrent NF1 and ATRX-Deficient/ALT-Positive High-Grade Solid Tumors

Cancers(2022)10.3390/cancers14123015

N/A

0DataRank · unranked

17 citations

Charles G. Eberhart, Christine A. Pratilas, Jaishri O. Blakeley, Christine Davis, Marija Stojanova +5 more

Therapeutic vulnerability to ATR inhibition in concurrent NF1 and ATRX- deficient high-grade solid tumors

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.03.479021

N/A

0DataRank · unranked

3 citations

Charles G. Eberhart, Christine A. Pratilas, Jaishri O. Blakeley, Christine Davis, Marija Stojanova +5 more

Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.29.490078

N/A

0DataRank · unranked

1 citations

Alex T. Larsson, Ana Calizo, Kai Pollard, Xiaochun Zhang, Eric Conniff +16 more

CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0749

N/A

0DataRank · unranked

27 citations

Joshua J. Lingo, Courtney A. Kaemmer, Amanda Scherer, Akshaya Warrier, Ellen Voigt +20 more

Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2548

N/A

0DataRank · unranked

24 citations

Breanne Burgess, Emily White, Abbi E. Smith, Elizabeth A. Sierra Potchanant, Henry Mang +16 more

MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3722

N/A

0DataRank · unranked

21 citations

Neha V. Amin, Kevin He, Xiaochun Zhang, Yang Lyu, Carina Dehner +10 more

Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0258

N/A

0DataRank · unranked

2 citations

Eunüs S. Ali, Marcela Krečmerová, Joanna Marie H. Aguilar, Jesse Alt, Diane E. Peters +11 more

CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.02.526674

N/A

0DataRank · unranked

5 citations

Ana Calizo, Lindy Zhang, James C. Pino, Yang Lyu, Kai Pollard +11 more

Patterns of Failure in Pediatric and Young Adult Rhabdomyosarcoma

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.1752

N/A

0DataRank · unranked

0 citations

Shanlin Ke, Chen Hu, P. Debs, Leslie Chang, John Gross +4 more

Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0797

N/A

0DataRank · unranked

22 citations

Jeffrey J. Szymanski, Alexander Pan, Paul A. Jones, Sana Mahmood, Olivia H. Reid +24 more

Targeting rapid TKI ‐induced AXL upregulation overcomes adaptive ERK reactivation and exerts antileukemic effects in FLT3 / ITD acute myeloid leukemia

Molecular Oncology(2024)10.1002/1878-0261.13749

N/A

0DataRank · unranked

4 citations

Li Li, J. Kyle Bruner, Melody Chou, Bao Nguyen, Jaesung Seo +5 more

Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion

JCO Precision Oncology(2024)10.1200/po.24.00254

N/A

0DataRank · unranked

5 citations

Jaime Wehr, Katerina Karaindrou, Rena R. Xian, Christopher D. Gocke, Ming‐Tseh Lin +35 more

Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics

medRxiv(2024)10.1101/2024.01.18.24301053

N/A

0DataRank · unranked

3 citations

Jeffrey J. Szymanski, Alexander Pan, Paul A. Jones, Sana Mahmood, Olivia H. Reid +24 more

Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors

Nature Communications(2025)10.1038/s41467-025-63619-4

N/A

0DataRank · unranked

2 citations

Jingyi Shi, Jianan Liu, Nihao Sun, Yuqing Lu, Xiaojun Chen +13 more

Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-25-0022

N/A

0DataRank · unranked

2 citations

Stacey Stauffer, Hyun Lee, Kristine A. Isanogle, Ying Wu, Katie Powell +17 more

Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors

Molecular Medicine(2025)10.1186/s10020-025-01353-9

N/A

0DataRank · unranked

2 citations

Arnab Sarkar, Natalia García, Lindy Zhang, Ana Calizo, Alla Lisok +11 more

DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3029

N/A

0DataRank · unranked

1 citations

Kylee Brewster, Stavriani C. Makri, Jaffar Khan, Eric A. Albright, Andrew Horvai +22 more

Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors

Cancer Research(2020)10.1158/0008-5472.can-20-1365

N/A

0DataRank · unranked

65 citations

Kai Pollard, Amy N. Allen, Tushar Tomar, Dirk Pijnenburg, Zhan Yao +3 more

Activation of Receptor Tyrosine Kinases Mediates Acquired Resistance to MEK Inhibition in Malignant Peripheral Nerve Sheath Tumors

Cancer Research(2020)10.1158/0008-5472.can-20-1992

N/A

0DataRank · unranked

47 citations

Kai Pollard, Ana Calizo, Christine A. Pratilas, Jiawan Wang

Christine A. Pratilas

Indexed papers

Top data-sharing exemplar

Papers